<DOC>
	<DOCNO>NCT00085956</DOCNO>
	<brief_summary>The purpose study determine : - The effect arzoxifene bone mineral density ( bone mass ) spine hip postmenopausal woman . - The effect arzoxifene uterus ( womb ) postmenopausal woman . - The effect arzoxifene blood test measure change bone rebuild postmenopausal woman low bone density . - The effect arzoxifene blood lipid ( fat ) blood marker heart disease risk . - The safety arzoxifene side effect might associate use .</brief_summary>
	<brief_title>Effects Arzoxifene Bone Mass Uterus</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<criteria>Female 45 60 year age , inclusive At least 2 year since last menstrual cycle Intact uterus ( womb ) . Existing fracture spine . Bone disorder , low bone mass History cancer last 5 year . Also , history , time , breast cancer cancer line uterus . Abnormal unexplained vaginal bleeding .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>